Clinical Trial Update: Genistein in Treating Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of Genistein in prostate cancer patients has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Prostate
• Prostate Cancer

Drugs mentioned

• Genistein (genistein)

Snippet

Sponsor: Northwestern University | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-07-02